Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial - The Lancet Oncology
IC Montecchio 1
IC VICENZA 1 – F. MAFFEI (S. CATERINA) – IC Vicenza 1